CLMT vs CVS · rev $4.19B vs P/E 16, rev $402.07B
Calumet Specialty Products Partners (CLMT) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CLMT revenue for 2024-12-31 was $4.19B. Net income was -$222.0M. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. CLMT currently screens at market cap $2.89B.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CLMT currently screens at market cap $2.89B. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CLMT and CVS stock pages for the full models.
Not investment advice.